Table 1.
Endpoint Terms “overall survival” OR “progression-free survival” OR “event-free survival” OR “disease-free survival” OR (“response rate*” AND trial* AND endpoint*) OR “tumor response” OR “overall response rate*” OR “objective response rate*” OR “duration of response” OR “time to progression” OR “time to treatment failure” OR “surrogate outcome*” OR “surrogate endpoint*” OR “secondary endpoint*” OR “clinical endpoint*” OR “clinical trial endpoint*” OR “clinical trial outcome*” (in the abstract or title) AND Oncology Terms oncology OR oncological OR hematological OR cancer* (in the abstract or title or keyword) AND Patient Understanding Terms “patient* knowledge” OR “patient* understand*” OR “patient* perception*” OR “patient* comprehen*” OR “patient* view*” OR “patient* misunderstand*” OR “patient* misunderstood” OR “patient* perceive*” OR “consumer* knowledge” OR “consumer* understand*” OR “consumer* perception*” OR “consumer* comprehen*” OR “consumer* view*” OR “consumer* misunderstand*” OR “consumer* misunderstood” OR “consumer* perceive*” OR “lay knowledge” OR “lay understand*” OR “lay perception*” OR “lay comprehen*” OR “lay view*” OR “lay misunderstand*” OR “lay misunderstood” OR “lay perceive*” OR “public* knowledge” OR “public* understand*” OR “public* perception*” OR “public* comprehen*” OR “public* view*” OR “public* misunderstand*” OR “public* misunderstood” OR “public perceive*” (in the abstract or title) OR ((patient* OR consumer* OR lay OR public) AND (misunderstand* OR misunderstood* OR understand* OR knowledge* OR perception* OR perceive* OR comprehen* OR view*)) (in the title) |